10 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 10 of 10 clinical reviews.
A guide to off-label Vyvanse use in adolescents ages 12 to 17, covering binge eating disorder, depression augmentation, and fatigue, with trial data, dosing, and safety considerations.
A guide to prescribing Vyvanse (lisdexamfetamine) in patients 65 and older, covering geriatric pharmacokinetics, cardiovascular risk, dose titration, and transition from pediatric or young-adult care.
A guide to off-label Vyvanse (lisdexamfetamine) use in adults 65 and older, covering pharmacokinetics, cardiovascular risk, ADHD evidence, renal dosing, and safer prescribing strategies for geriatric patients.
Everything families and clinicians need to know about managing Vyvanse therapy in children under 12 and planning a safe, evidence-based handoff to adult care.
A guide to lisdexamfetamine (Vyvanse) use in adolescents aged 12 to 17, covering academic performance, sports participation, sleep, appetite, and school accommodation planning.
A guide to transitioning adolescents on Vyvanse (lisdexamfetamine) to adult ADHD care, including dosing, monitoring, insurance, and what to expect at age 18.
A guide to administering Vyvanse (lisdexamfetamine) to children under 12, covering FDA-approved dosing, mixing instructions, food interactions, missed doses, storage, and safety monitoring.
A guide to lisdexamfetamine (Vyvanse) use in patients 65 and older, covering pharmacokinetics, cardiovascular risk, cognitive effects, dosing, and the limited evidence base for this age group.
A guide to managing Vyvanse (lisdexamfetamine) in children under 12, covering classroom performance, after-school activities, dosing timing, appetite, and safety monitoring.
A guide to the developmental effects of Vyvanse (lisdexamfetamine) in children under 12, covering growth, brain development, behavior, and long-term safety evidence.